C1–C2-linker substituted 1,5-naphthyridine analogues of oxabicyclooctane-linked NBTIs as broad-spectrum antibacterial agents (part 7)

No abstract is available for this paper.

• Publication year

  2015

• Venue

  MedChemComm

• Publication date

  2015-10-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/C5MD00297D
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2).

  2015cited by this paper
• Hydroxy tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of RHS moiety (Part-3).

  2015cited by this paper
• Novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram positive activity and improved safety profile.

  2015cited by this paper
• Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5).

  2015cited by this paper
• Structure activity relationship of pyridoxazinone substituted RHS analogs of oxabicyclooctane-linked 1,5-naphthyridinyl novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-6).

  2015cited by this paper
• Determination of Disk Diffusion and MIC Quality Control Guidelines for GSK2140944, a Novel Bacterial Type II Topoisomerase Inhibitor Antimicrobial Agent

  2014cited by this paper
• Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents.

  2014cited by this paper
• Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases.

  2013cited by this paper
• Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.

  2013cited by this paper
• Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity.

  2013cited by this paper
• Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile.

  2012cited by this paper
• Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases.

  2011cited by this paper
• Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activity.

  2011cited by this paper
• Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases.

  2011cited by this paper
• Type IIA topoisomerase inhibition by a new class of antibacterial agents

  2010cited by this paper
• New inhibitors of bacterial topoisomerase GyrA/ParC subunits.

  2009cited by this paper
• Mechanism of Action of the Antibiotic NXL101, a Novel Nonfluoroquinolone Inhibitor of Bacterial Type II Topoisomerases

  2008cited by this paper
• Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.

  2007cited by this paper
• Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.

  2007cited by this paper

• Antimicrobial Activity of Naphthyridine Derivatives

  2024cites this paper
• 2-Oxabicyclo[2.2.2]octane as a new bioisostere of the phenyl ring

  2023cites this paper
• The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV

  2022cites this paper
• Recent advances in DNA gyrase-targeted antimicrobial agents.

  2020cites this paper
• Synthetic Strategies, Reactivity and Applications of 1,5-Naphthyridines

  2020cites this paper
• New strategy on antimicrobial-resistance: inhibitors of DNA replication enzymes.

  2019cites this paper
• Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site

  2018cites this paper
• Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.

  2017cites this paper
• In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase

  2016cites this paper